Los Angeles Capital Management LLC Buys 2,546 Shares of Humana Inc. (NYSE:HUM)

Los Angeles Capital Management LLC lifted its stake in shares of Humana Inc. (NYSE:HUMFree Report) by 11.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,625 shares of the insurance provider’s stock after purchasing an additional 2,546 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Humana were worth $8,885,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. CWM LLC boosted its holdings in Humana by 12.6% in the first quarter. CWM LLC now owns 2,623 shares of the insurance provider’s stock worth $909,000 after acquiring an additional 293 shares in the last quarter. Kapitalo Investimentos Ltda grew its position in Humana by 31.9% in the 4th quarter. Kapitalo Investimentos Ltda now owns 1,075 shares of the insurance provider’s stock valued at $492,000 after purchasing an additional 260 shares during the period. HighPoint Advisor Group LLC bought a new stake in Humana during the 4th quarter valued at $457,000. Grayhawk Investment Strategies Inc. bought a new position in shares of Humana in the fourth quarter valued at $711,000. Finally, B. Riley Wealth Advisors Inc. increased its position in shares of Humana by 15.8% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 2,041 shares of the insurance provider’s stock worth $936,000 after acquiring an additional 278 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Wells Fargo & Company cut their price target on Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. TD Cowen lowered their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a report on Tuesday, April 2nd. Raymond James initiated coverage on shares of Humana in a report on Friday, March 22nd. They set a “market perform” rating on the stock. Bank of America increased their price objective on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research note on Monday, May 20th. Finally, Royal Bank of Canada cut their target price on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research note on Thursday, April 25th. Thirteen investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $423.63.

Read Our Latest Stock Report on HUM

Humana Stock Performance

Shares of HUM stock opened at $349.55 on Thursday. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The stock has a market capitalization of $42.12 billion, a P/E ratio of 21.77, a PEG ratio of 2.05 and a beta of 0.53. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The firm’s 50 day moving average is $338.49 and its 200 day moving average is $356.83.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the business earned $9.38 earnings per share. On average, sell-side analysts anticipate that Humana Inc. will post 16.07 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is presently 22.04%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.